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Background: Previous studies suggested that high dietary carbohydrate intake is associated with increased
cardiovascular risk through raised triglyceride and decreased high-density lipoprotein-cholesterol levels. However,
the relation between carbohydrate intake and arterial stiffness has not been established. The purpose of this study
was to examine this relation among high-risk cardiovascular patients.
Methods: We studied the relation between dietary macronutrient intake and arterial stiffness in 364 patients with
documented cardiovascular diseases or risk equivalent (coronary artery diseases 62%, ischemic stroke 13%, diabetes
mellitus 55%) and in 93 age-and-sex matched control subjects. Dietary macronutrient intake was assessed using a
validated food-frequency questionnaire (FFQ) for Chinese. Heart-ankle pulse wave velocity (PWV) was measured
non-invasively with a Vascular Profiling System (VP2000, Colin Corp. USA). A dietary pattern with ≥60% total energy
intake derived from carbohydrates was defined as a high-carbohydrate diet according to the Dietary Reference
Intakes (DRI) for Chinese.
Results: Subjects who consumed a high-carbohydrate diet had significantly higher mean PWV than those who did
not consume a high-carbohydrate diet (P = 0.039). After adjustment for potential confounders, high-carbohydrate
diet was associated with significantly increased PWV [B = 73.50 (10.81 to 136.19), P = 0.022]. However, there was no
significant association between high-carbohydrate diet and PWV in controls (P = 0.634).
Conclusions: High-carbohydrate diet is associated with increased arterial stiffness in patients with established
cardiovascular disease or risk equivalent.
Keywords: Macronutrient, Carbohydrate intake, Arterial stiffness, Pulse wave velocity, Secondary preventionBackground
Epidemiological studies suggested that dietary macronutri-
ents intake could modify the risk of cardiovascular disease
(CVD) [1]. A dietary pattern with high carbohydrate intake
from fruits, vegetables, whole grain cereals and low-fat
dairy products, but low in saturated fat and total fat, also
known as the Dietary Approaches to Stop Hypertension
(DASH), has been shown to prevent CVD [2,3]. On the
other hand, replacement of carbohydrate with protein or* Correspondence: hftse@hkucc.hku.hk
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reproduction in any medium, provided the orunsaturated fat in diet has also been suggested to reduce
the risk of CVD [4]. Indeed, a lower percentage of energy
intake from carbohydrate was associated with decreased
blood pressure, plasma triglyceride and low-density
lipoprotein cholesterol (LDL-C), and increased high-density
lipoprotein cholesterol (HDL-C) [1,5,6]. Conversely, a higher
carbohydrate intake may induce hypertriacylglycerolemia [7].
In the Optimal Macronutrient Intake Trial to Prevent Heart
Disease study, a low carbohydrate diet (partial replacement
of carbohydrate with either protein or unsaturated fat)
reduced blood pressure, decreased low-density lipoprotein
cholesterol and heart disease risk in prehypertensive
individuals [1,6]. In the Nurses’ Health Study, glycemictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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healthy postmenopausal women [8]. In a study of healthy
Korean adults, high carbohydrate intake (70% of energy
intake) was associated with higher body-mass index
(BMI), blood pressure, fasting glucose, triglycerides
and LDL-cholesterol levels [9]. Furthermore, among
insulin-resistant and obese persons, excessive intake
of energy from carbohydrate >60% was associated
with unfavorable changes in the lipid profile [6]. Even
in patients with non-cardiometabolic chronic diseases,
such as women previously treated for breast cancer,
high carbohydrate intake was showed to increase fasting
level of triacylglycerol [10].
Apart from its effects on the lipid profile, higher
carbohydrate consumption also suppresses vascular endo-
thelial function as demonstrated by reduced endothelium-
dependent flow-mediated dilation (FMD) [8]. Furthermore,
a small pilot study showed that moderate carbohydrate
intake can improve arterial stiffness and ambulatory blood
pressure [9]. However, whether increased carbohydrate
intake may alter atherosclerotic progression in patients
with established cardiovascular disease remained unclear.
In this study, we sought to investigate the relation between
dietary macronutrients intake and arterial stiffness in a
group of Chinese subjects with established CVD.
Methods
Study Populations
This study comprised 364 consecutive patients with
established CVD or risk equivalent, recruited from our
outpatient medical clinic. Established CVD included
prior coronary artery disease and ischemic stroke, while
CVD risk equivalence refers to conditions which confer
equivalent cardiovascular risk and in our study context
included patients with type II diabetes mellitus but
without prior CAD/ ischemic stroke. Inclusion criteria
constitute a homogeneous sample of subjects with
presence of established coronary disease or factors
considered to be of equivalent risks (i.e. ischemic
stroke or diabetes mellitus) which place subjects at the
medium to advanced spectrum of the cardiovascular
continuum [7]. Diagnosis of coronary artery disease was
established in the presence of any of the following: a
history of myocardial infarction; a history suggestive of
angina pectoris objectively evidenced by inducible ischemia
on exercise treadmill or SPECT; and the presence of
coronary atherosclerosis as defined by coronary angi-
ography, computed tomography or magnetic resonance
imaging. Diagnosis of ischemic stroke was made on the
basis of clinical examinations and computed tomography
brain imaging. Patients with type II DM were defined by
WHO criteria [10]. Exclusion criteria constituted presence
of non-conventional or non-cardiovascular factors which
may present important confounding effects that mayresult in biased estimates of the relations under study
or that may cause temporary potential fluctuations in
vascular function parameters. These included dilated
cardiomyopathy, pregnancy, history of heart failure,
significant valvular heart disease, chronic atrial fibrillation,
renal failure (serum creatinine > 1.2 mg/dL), cancer,
recent myocardial infarction, unstable angina, or coronary
revascularization within the past 6 months
During the study period, 93 age- and sex-matched healthy
Chinese controls free from history of CVD or diabetes were
recruited from a community health screening programme
for comparison. The study was approved by the local
ethics committee, the Institutional Review Board (IRB) of
the University of Hong Kong/ Hospital Authority
Hong Kong West Cluster (IRB, HKU/HA HKW Cluster).
All participants understood and signed informed consent
forms.Demographic and clinical assessment
Demographic and clinical data were collected by an
interviewer-administered structured questionnaire. Car-
diovascular risk factors including tobacco smoking,
hypercholesterolemia, hypertension, family history of
CVD diagnosed in first-degree relatives before 55 years
of age were assessed. Use of cardiovascular medications
was recorded. Anthropometric measurements including
body weight, height, and waist-hip circumferences ratio
were measured. Body mass index (BMI) was then calcu-
lated in kg/m [2]. Systolic and diastolic blood pressures
were measured. Fasting venous blood sample was obtained
from all patients to measure serum glucose, HbA1c, trigly-
ceride, total cholesterol, LDL-C and HDL-C levels.Dietary assessment
A validated food frequency questionnaire (FFQ) for
Chinese were used to assess dietary intake of all sub-
jects over the past 6 months prior to date of inter-
view, as described previously [11-13]. Briefly, subjects
were assessed for frequency (day/week/month/year)
and amount (unit of intake: liangs, equivalent to
37.8 g) intake of particular food past year, and 72
major food groups were recorded in FFQ. Types of
fruit assessed included apples, pears, tangerines/oranges/
grapefruits, bananas, grapes, watermelon, peaches and
other fruits. Pictures of food with household units were
shown to subjects to increase the accuracy of record.
The conversion of dietary nutrients was performed
by custom-made software as used in the Shanghai
Women’s health Study [12]. High Carbohydrate diet was
defined as daily carbohydrate intake of ≥60% of total
energy, i.e. above the daily recommended intake (DRI) of
carbohydrate at 60% of total energy (Chinese Nutrition
Society) [14].
Table 1 Characteristics of the study population and control subjects
Study population (n = 364) Control (n = 93) P-value
Characteristics Mean (± SD) Mean (± SD)
Age (years) 66.2 ± 10.2 65.3 ± 7.1 0.417
Male, n (%) 233 (64%) 49 (53%) 0.056
BMI (kg/m2) 24.99 ± 3.30 23.80 ± 3.40 0.002*
Waist-to-hip ratio 0.93 ± 0.06 0.91 ± 0.08 <0.001*
Ischemic stroke, n (%) 49 (13.46) —— <0.001*
Coronary artery disease, n (%) 224 (61.54) —— <0.001*
Diabetes mellitus, n (%) 200 (54.95) —— <0.001*
Hypertension, n (%) 232 (63.74) 22 (23.66) <0.001*
Hyperlipidaemia, n (%) 232 (63.74) 30 (32.26) <0.001*
Smokers, n (%) 165 (45.33) 14 (15.05) <0.001*
Systolic blood pressure (mmHg) 141.00 ± 19.85 127.82 ± 18.04 <0.001*
Diastolic blood pressure (mmHg) 79.16 ± 9.19 75.06 ± 9.32 <0.001*
Total serum cholesterol (mmol/L) 4.50 ± 0.89 5.12 ± 0.83 <0.001*
Serum HDL-C (mmol/L) 1.28 ± 0.34 1.48 ± 0.40 <0.001*
Serum LDL-C (mmol/L) 2.56 ± 0.72 3.05 ± 0.76 <0.001*
Serum triacylglycerol (mmol/L) 1.49 ± 0.97 1.34 ± 0.74 0.167
Fasting glucose (mmol/L) 6.36 ± 2.07 5.16 ± 0.60 <0.001*
HbA1c (%) 7.05 ± 1.48 6.63 ± 5.33 0.192
Medications
Beta-blocker, n (%) 184 (50.55) 6 (6.5) <0.001*
ACEI/ARB, n (%) 36 (9.9) ——— <0.001*
Statin, n (%) 226 (62.09) 3 (3.2) <0.001*
PWV (cm/s) 1102.17 ± 144.54 1079.48 ± 135.09 0.172
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; PWV, pulse wave velocity.; HDL-c, high-density lipoprotein cholesterol;
LDL-c, low-density lipoprotein cholesterol.
*p-value <0.05.
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Arterial stiffness was measured non-invasively using
Vascular Profiling System VP-2000 (Colin Corp., USA).
All measurements were performed by a single experienced
operator. Patients were allowed to rest in the supine
position for 5 minutes in a quiet room before examination.
Initially, the sites of maximum carotid and posterior
popliteal arteries pulsation were determined by physical
examination. Sequential recordings of pressure wave-forms
at the precordium and the posterior popliteal arteries
were made using hand-held manometer probes with
simultaneous electrocardiogram gating. Measurement
was taken after achieving coherent reproduction of
signals with maximum amplitudes. Heart-ankle pulse
wave velocity (PWV) was defined as the distance between
the 2 points of measurement over the precordium and the
respective posterior popliteal artery, divided by pulse
transit time between the systolic R-wave and the upstroke
of waveform at the posterior popliteal artery, and was cal-
culated using system software with R-wave synchronisationover at least 10 cardiac cycles. A final estimate was
derived from the average of the values from the bilateral
measurements. Intra-observer variability testing revealed
an intra-class correlation coefficient (two-way mixed,
random-effect model, absolute agreement) of 0.87 (95%
CI: 0.80 to 0.91, P < 0.001) for PWV measurement.
Statistical Methods
Continuous variables are expressed as mean ± SDs, and
categorical data are presented as frequency and percentages.
Statistical comparisons were performed by using Student’s t
test, Pearson’s χ2 test, or the Fisher’s exact test, as appropri-
ate. Absolute changes and 95% CIs of PWV were calculated
by using univariate and multivariate linear regression
analysis. Multivariate analyses were performed such that
potentially confounding variables and known variables
involved in prediction of PWV were chosen, including use
of antihypertensive medications and statin [15,16]. Each
independent variable was considered a potential confounder
if the p-value was <0.20 based on univariate analysis, and
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Multivariate linear regression analysis was repeated using
the overall sample including all subjects, as well as
separately among patients with CVD risk equivalent
versus healthy controls. In the Full Model, all independent
variables were entered and adjusted for all (Table 1). All
data analyses were performed using the Statistical Package
for the Social Sciences (version 16.0, SPSS). A value of P
value less than 0.05 was considered statistically significant.
Results
Baseline characteristics
The baseline characteristics of the study population were
shown in Table 1. Their mean age was 66.2 ± 10.2 years
and 64% of the participants were men. Among them,
62% had documented coronary artery disease, 55% had
type II diabetes mellitus and13% had ischemic stroke.
Among them, 64% of patients had hypertension and 64%
had hyperlipidaemia. And 45% of patients were smokers.
The daily dietary profiles of the study population as
measured by FFQ were presented in Table 2. The
percentage of energy intake derived from carbohydrate,
protein and fat were 72.3 ± 7.6%, 15.2 ± 2.9% and
12.5 ± 5.4%, respectively. Energy intake was significantly
reduced among cases compared to controls (P < 0.001),
with different pattern of intake of major food groups.Table 2 Dietary profile of the study population and control s
Study population (n
Characteristics Mean (± SD)
Energy intake/day (Kcal/d) 1978.22 ± 725.57
Carbohydrate (g/d) 359.85 ± 145.80
High carbohydrate diet (≧60%) (n,%) 346 (95.05)
Protein (g/d) 73.95 ± 27.43
Fat (g/d) 26.97 ± 15.48
Carbohydrate (% of energy ) 72.32 ± 7.62
Protein (% of energy ) 15.21 ± 2.94
Fat (% of energy ) 12.46 ± 5.39
Rice 451.63 ± 191.80
Vegetables 132.78 ± 98.82
Meat 61.41 ± 58.41
Poultry 19.09 ± 20.85
Fish 68.23 ± 70.13
Egg 9.25 ± 12.72
Fruit 53.95 ± 40.80
Soy 32.79 ± 45.75
Fiber 9.26 ± 6.33
Saturated fat 7.00 ± 4.72
Polyunsaturated fatty acids 5.06 ± 2.63
*P < 0.05 Significantly different from high carbohydrate diet and without high carboEffects of dietary high carbohydrate diet on blood
pressure and lipid profile
As shown in Table 3, high carbohydrate diet was signifi-
cantly associated with increased systolic blood pressure
[B = 2.86, 95% CI( 1.96 to 3.76), P < 0.001], adjusted for
age and sex. However, no significant differences were
seen in subjects with high carbohydrate diet in terms
of diastolic blood pressure, serum LDL-c, HDL-c, and
triacylglycerol (P > 0.05).
Effects of high carbohydrate diet on pulse wave velocity
In univariate analysis, high-carbohydrate diet was associ-
ated with significantly increased PWV among patients with
CVD risk equivalent [B = 72.21, 95% CI (3.80 to 140.62),
P = 0.039]. Similar association was found among the
overall study sample (n = 457) with marginal statistical
significance [B = 50.52, 95% CI (-6.03 to 107.07), P = 0.080].
Adjusted for potential confounders (including age, sex,
diabetes mellitus, smokers, hypertension, hyperlipidaemia,
cardiovascular diseases, BMI, and use of medications,
including beta-blocker, angiotensin-converting enzyme
inhibitor/ angiotensin receptor blocker and statins),
dietary energy intake, saturated fat, polyunsaturated fat,
monounsaturated fat, fiber, high-carbohydrate diet remained
independently associated with PWV [B = 73.50 (10.81 to
136.19), P = 0.022, Table 4]. Repeated analysis using Fullubjects
= 364) Control subjects (n = 93) P-value
Mean (± SD)
2393.10 ± 836.76 <0.001*
436.88 ± 168.39 <0.001*
85 (91.40) 0.207
87.06 ± 35.26 <0.001*
32.98 ± 17.70 0.001*
72.54 ± 8.80 0.807
14.81 ± 3.68 0.271
12.63 ± 5.76 0.794
539.36 ± 221.40 <0.001*
161.07 ± 109.71 0.016*
79.25 ± 112.54 0.035*
23.85 ± 25.77 0.062
63.56 ± 53.48 0.549
9.50 ± 11.00 0.864
70.13 ± 48.98 0.001*
49.80 ± 71.00 0.005*
10.63 ± 4.72 0.051
9.08 ± 6.43 <0.001*
6.15 ± 3.51 0.002*
hydrate diet (independent sample t-test).
Table 3 Effects of high-carbohydrate diet on blood
pressure and serum lipid profilea
B (95% CI) Adjusted
p-value
Systolic blood pressure (mmHg)
Without high carbohydrate
diet (<60%)
High carbohydrate diet (≧60%) 2.86 (1.96 to 3.76) <0.001*
Diastolic blood pressure (mmHg)
Without high carbohydrate
diet (<60%)
















High carbohydrate (≧60%) -2.80 (-28.87 to 23.27) 0.833
aAdjusted for age and sex.
*p-value<0.05.
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375.58), P = 0.003]. Nevertheless, no significant association
was observed between carbohydrate intake and PWV
in healthy controls [B = -28.52, 95% CI (-147.83 to 90.80),
P = 0.634, Table 4].
Discussion
High-carbohydrate diet is associated with increased car-
diovascular risk [17-19], in terms of adverse changes in
cardiovascular risk factors, such as raised serum tri-
glycerides and reduced levels of high-density lipoprotein
cholesterol, but its relation with vascular function re-
mained unclear. In coherence with an earlier small pilot
study showing that moderate carbohydrate diet reduced
PWV [9], this study further shows that high-carbohydrate
diet is independently associated with increased PWV in
patients with established cardiovascular disease or risk
equivalent. Arterial stiffness as measured by PWV has
been shown to be an important clinical marker of
atherosclerosis [20,21], and is a predictor of cardiovascular
events in healthy subjects beyond traditional risk factors[22]. The results of this study suggest that increased
carbohydrate intake in patients with established cardiovas-
cular disease or risk equivalent may potentially contribute
to further increased risk of future cardiovascular events
through accelerated progression of atherosclerosis. The
mechanisms linking arterial stiffness to CVD are not com-
pletely understood, and may involve insulin resistance
promoting endothelial dysfunction, oxidative stress,
vascular smooth muscle cell growth and stimulation of
the sympathetic nervous system [23].
There are several possible mechanistic pathways
through which high-carbohydrate diet could impact on
atherosclerosis, and these included changes in blood
pressure, lipid profile, or modulation of inflammatory
cytokines and the nitric oxide system [24,25]. In this
study, increased carbohydrate intake is associated with
raised systolic blood pressure, which is consistent with
the previous finding of beneficial changes in ambulatory
blood pressure associated with a low glycemic index diet
[9]. No changes were observed in glycemic and lipid
profiles in this study in relation to a high carbohydrate
diet. These findings suggest that high-carbohydrate diet
may affect arterial stiffness through altering BP but not
lipid profile.
Notably, the percentage of smokers among patients
with established cardiovascular diseases was markedly
higher than that among control subjects (45.3% versus
15.1%, P < 0.001). The adverse effects of cigarette smoke
in atherogenesis are indispensible, mediated by multiple
pathways including free radical-induced oxidative stress
as well as pro-thrombotic and pro-inflammatory cas-
cades [26]. We therefore carefully adjusted for the ef-
fects of smoking in the multivariate analysis, and
showed that the pro-atherosclerotic effects of high
carbohydrate diet were independent of smoking. Inter-
estingly, the pro-atherosclerotic effect of high carbohy-
drate diet was present in patients with cardiovascular
disease or risk equivalent, but not in healthy control
subjects. This suggests that high carbohydrate diet
may preferentially affect the most susceptible patients
at the advanced spectrum of the cardiovascular con-
tinuum. This implies that dietary interventions [27] to
reduce habitual carbohydrate intake may have an im-
portant role in secondary prevention of cardiovascular
disease.
Study limitations
First, the glycemic index was not determined in this
study, therefore direct comparison with previous studies
could be difficult and the specific type of carbohydrate
cannot be ascertained. Second, a direct causality of dietary
carbohydrate intake and arterial stiffness cannot be
established in a cross-sectional setting. Furthermore, the
method in measuring heart-ankle PWV was not a priori
Table 4 Unadjusted and adjusted relations of high carbohydrate intake with PWV in study population and control subjects









β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
Age 6.61 (5.39 to 7.83) <0.001* 6.68 (5.42 to 7.94) <0.001* 6.27 (4.93 to 7.61) <0.001* 9.88 (5.77 to 13.99) <0.001*
Male 28.08 (1.17 to 55.00) 0.041 33.38 (8.40 to 58.36) 0.009* 23.55 (-4.46 to 51.56) 0.099 67.87 (10.17 to 125.58) 0.022*
Diabetes mellitus 18.81 (-8.19 to 45.80) 0.172 46.34 (18.93 to 73.76) 0.001* 43.18 (15.22 to 71.14) 0.003* 150.75 (-88.20 to 389.71) 0.212
Hypertension 69.97 (44.07 to 95.87) <0.001* 53.52 (27.82 to 79.21) <0.001* 58.61 (30.39 to 86.83) <0.001* 22.69 (-45.87 to 91.25) 0.511
Hyperlipidaemia 13.60 (-13.88 to 41.08) 0.331
Past or current smokers 49.39 (-67.71 to 166.48) 0.401
BMI -1.14 (-5.07 to 2.79) 0.569
Medications
Beta-blocker 22.17 (-5.02 to 49.36) 0.110 -0.90 (-27.55 to 25.75) 0.95 0.29 (-27.35 to 27.92) 0.984 -17.61 (-130.81 to 95.60) 0.757
ACEI/ARB 19.31 (-29.41 to 68.03) 0.436
Statin 6.17 (-20.43 to 32.76) 0.649
Dietary energy intake 0.003 (-0.015 to 0.020) 0.769
Saturated fatty acid -2.31 (-4.84 to 0.22) 0.074 -0.58 (-3.03 to 1.87) 0.643 0.47 (-2.42 to 3.35) 0.750 -3.39 (-8.07 to 1.28) 0.151
PUFA -2.12 (-6.71 to 2.47) 0.364
MUFA -4.97 (-2.33 to 1.33) 0.594
Fiber -0.103 (-2.28 to 2.07) 0.926
CVD/risk equivalent3 22.68 (-9.90 to 55.26) 0.172 -51.81 (-90.32 to -13.30) 0.008* - - - -
High carbohydrate
diet (≧60%)
50.52 (-6.03 to 107.07) 0.080 52.46 (-3.09 to 108.01) 0.064 73.50 (10.81 to 136.19) Full Model Estimate2:
231.39 (87.19 to 375.58)
0.022* 0.003* -28.52 (-147.83 to 90.80) 0.634
CI, confidence interval; CVD, cardiovascular disease; BMI, body-mass index; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; PUFA, polyunsaturated fatty acid; MUFA monounsaturated
fatty acid; PWV, pulse wave velocity.
1Multivariate Model, adjusted for potential confounders with p-value <0.20 based on univariate analysis.
2Full Model – Entered and adjusted for all independent variables.
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patient sample (n = 364) and the control sample (n = 93),
and the small number of subjects with low carbohydrate
intake, also limits the conclusions draw from the multi-
variate analysis as well as the statistical power of the study.
Future large randomized controlled studies will be import-
ant to confirm the causality by investigating the potentially
protective effects of reduced carbohydrate intake against
atherosclerotic progression in patients with high risk of
cardiovascular events.
Conclusions
High habitual carbohydrate intake is associated with in-
creased arterial stiffness in patients with established car-
diovascular disease or risk equivalent.
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